Acquired Gray Platelet Syndrome Associated with Primary Myelofibrosis-Reference-Cited by-同舟云学术

Acquired Gray Platelet Syndrome Associated with Primary Myelofibrosis

Published:2020-11-01 Issue:21 Volume:59 Page:2751-2756
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Ido Kentaro¹,Nakane Takahiko¹,Tanizawa Nao¹,Makuuchi Yosuke¹,Okamura Hiroshi¹,Koh Shiro¹,Nanno Satoru¹,Nishimoto Mitsutaka¹,Hirose Asao¹,Nakamae Mika¹,Nakashima Yasuhiro¹,Koh Hideo¹,Hino Masayuki¹,Nakamae Hirohisa¹

Affiliation:

1. Hematology, Graduate School of Medicine, Osaka City University, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/59/21/59_4912-20/_pdf

Reference33 articles.

1. 1. Tefferi A. Primary myelofibrosis: 2019 update on diagnosis, risk-stratification and management. Am J Hematol 93: 1551-1560, 2018.

2. 2. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th ed. Swerdlow SH, Campo E, Harris NL, et al., Eds. Myeloproliferative neoplasms. Lyon, 2017: 29-60.

3. 3. Martin K. Risk factors for and management of MPN-associated bleeding and thrombosis. Curr Hematol Malig Rep 12: 389-396, 2017.

4. 4. Kc D, Falchi L, Verstovsek S. The underappreciated risk of thrombosis and bleeding in patients with myelofibrosis: a review. Ann Hematol 96: 1595-1604, 2017.

5. 5. Appelmann I, Kreher S, Parmentier S, et al. Diagnosis, prevention, and management of bleeding episodes in Philadelphia-negative myeloproliferative neoplasms: recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) and the Society of Thrombosis and Hemostasis Research (GTH). Ann Hematol 95: 707-718, 2016.